Acumen Pharmaceuticals, Inc.

of this Report (including Exhibit 99.1), is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject

Financial Statements and Exhibits. (d). Exhibits Exhibit No. Description 99.1 Corporate Presentation, dated January 12, 202 6 104 Cover Page Interactive Data Fi